89bio Inc (ETNB)
8.24
-0.34
(-3.96%)
USD |
NASDAQ |
Apr 25, 13:40
89bio Shareholders Equity (Quarterly): 536.31M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 536.31M |
| September 30, 2023 | 410.21M |
| June 30, 2023 | 441.99M |
| March 31, 2023 | 445.83M |
| December 31, 2022 | 151.83M |
| September 30, 2022 | 152.58M |
| June 30, 2022 | 80.18M |
| March 31, 2022 | 102.74M |
| December 31, 2021 | 125.96M |
| September 30, 2021 | 146.77M |
| Date | Value |
|---|---|
| June 30, 2021 | 172.70M |
| March 31, 2021 | 190.20M |
| December 31, 2020 | 202.96M |
| September 30, 2020 | 214.00M |
| June 30, 2020 | 69.77M |
| March 31, 2020 | 79.90M |
| December 31, 2019 | 89.94M |
| September 30, 2019 | -53.97M |
| June 30, 2019 | 12.81M |
| December 31, 2018 | -16.06M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-53.97M
Minimum
Sep 2019
536.31M
Maximum
Dec 2023
188.04M
Average
151.83M
Median
Dec 2022
Shareholders Equity (Quarterly) Benchmarks
| Madrigal Pharmaceuticals Inc | 405.33M |
| Akero Therapeutics Inc | 535.31M |
| Viking Therapeutics Inc | 348.42M |
| Galectin Therapeutics Inc | -60.24M |
| Terns Pharmaceuticals Inc | 255.37M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 596.27M |
| Total Liabilities (Quarterly) | 59.96M |